Loading...
•
Jun 30, 2020
CME Group Q2 2020 Earnings Report
CME Group's financial performance reflected resilience amidst the coronavirus pandemic, with increased focus on innovative products and strategic migrations.
Key Takeaways
CME Group reported Q2 2020 financial results with revenue of $1.2 billion and operating income of $638 million. Net income was $503 million, with diluted earnings per share at $1.40. Adjusted net income reached $583 million, and adjusted diluted earnings per share were $1.63.
Markets continued to help clients manage risk and navigate uncertainty during the coronavirus pandemic.
Employees ensured the resiliency of systems and effective operations of markets while working from home.
Innovative new products were delivered, including the reintroduction of 3-Year Treasury Note futures and new options on Micro E-mini Equity futures.
Focus remained on providing increased value to market participants through the migration of the BrokerTec business to CME Globex in Q4.
Revenue by Segment
Forward Guidance
CME Group is committed to promoting the safety of its employees while continuing to facilitate risk transfer and price discovery to help businesses and economies recover from the crisis.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...